NCT02248207View on ClinicalTrials.gov

Tolerability of Sifrol® in Ambulatory Patients Suffering From Parkinson's Disease

CompletedOBSERVATIONAL
Enrollment

1,293

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

November 30, 2003

Conditions
Parkinson Disease
Interventions
DRUG

Pramipexole

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02248207 - Tolerability of Sifrol® in Ambulatory Patients Suffering From Parkinson's Disease | Biotech Hunter | Biotech Hunter